IP Library Granted Patent US 7,235,370
Granted Patent B2
US 7,235,370 · App. 10/624,822 · Granted Jun 26, 2007

Site-specific aminoglycoside derivatives for use in immunodiagnostic assays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,370
App. No.
10/624,822
Granted
Jun 26, 2007
Kind
B2
Abstract

A method of making a derivatized aminoglycoside includes reacting an aminoglycoside with at least 2 equivalents of a divalent metal ion in an aprotic solvent to complex two neighboring amino group and hydroxyl group pairs; reacting the non-complexed amino groups with a protecting reagent to provide protecting groups; removing the divalent metal ion to provide two unprotected amino groups; reacting one of the unprotected amino groups with a reactive substance containing an linker, a carrier, or a label; and removing the protecting groups. This method can be used to produce novel compounds and reagents.

Claims (9)

1. An assay method for determining an aminoglycoside comprising:

combining a sample suspected of containing the aminoglycoside with an antibody specific for the aminoglycoside and with an aminoglycoside analog having the formula

wherein A is CH 2 NH 2 , CHCH 3 NH 2 , or CHCH 3 NHCH 3 ; B is H or OH; D is H or OH; E is NH 2 or OH; G′ is NH 2 , NHCH 3 , NH—T, or NCH 3 —T; J is H or OH; L is H, CH 3 , or OH; Q is H or CH 2 OH; Y′ is H, C(═O)CH(OH)CH 2 CH 2 NH 2 , or T; T is a label; and T is present in only one of G′ or Y′; and wherein the aminoglycoside analog and the aminoglycoside in the sample compete to form a detectable complex with the antibody; and

determining the presence or amount of the detectable complex as a measure of the aminoglycoside in the sample.

2. The assay method of claim 1 wherein the label is selected from the group consisting of enzymes, fluorescent compounds, luminescent compounds, radioactive isotopes, polymers, and microparticles.

3. An assay method according to claim 1 in which A is CH 2 NH 2 , B is H, D is H, E is NH 2 , G′ is NHCH 3 , J is OH, L is CH 3 , Q is H, and Y′ is

4. A test kit for determining an aminoglycoside in a sample comprising in packaged combination an antibody specific for the aminoglycoside and an aminoglycoside analog having the formula

wherein A is CH 2 NH 2 , CHCH 3 NH 2 , or CHCH 3 NHCH 3 ; B is H or OH; D is H or OH; E is NH 2 or OH; G′ is NH 2 , NHCH 3 , NH—T, or NCH 3 —T; J is H or OH; L is H, CH 3 , or OH; Q is H or CH 2 OH; Y′ is H, C(═O)CH(OH)CH 2 CH 2 NH 2 , or T; T is a label; and T is present in only one of G′ or Y′.

5. A test kit according to claim 4 in which A is CH 2 NH 2 , B is H, D is H, E is NH 2 , G′ is NHCH 3 , J is OH, L is CH 3 , Q is H, and Y′ is

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2004
From: ROCHE DIAGNOSTICS CORPORATION
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 015201/0368 →